DENTSPLY SIRONA Inc. ($XRAY) Stock Forecast: Down 0.9% Today

What is DENTSPLY SIRONA Inc.?

Dentsply Sirona Inc. (NASDAQ: XRAY) is a leading manufacturer of professional dental products and technologies. The company offers a comprehensive range of dental supplies and equipment to dentists worldwide.

Why is DENTSPLY SIRONA Inc. going down?

XRAY stock is down 0.9% on Jan 14, 2025 15:27

• The decline in XRAY's stock price is potentially linked to ongoing securities class action lawsuits against the company.
• Investor sentiment appears to be negative due to concerns over legal uncertainties, prompting a sell-off of XRAY shares.
• There is a looming deadline for investors to secure counsel by January 27, 2025, which may be further impacting the stock price.
• Overall, market sentiment towards XRAY is bearish as investors assess the potential implications of the legal proceedings on the company's financial performance and reputation.

XRAY Price Chart

XRAY Technical Analysis

XRAY News

ROSEN, HIGHLY RECOGNIZED INVESTOR COUNSEL, Encourages Dentsply Sirona Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - XRAY - Dentsply Sirona ( NASDAQ:XRAY )

NEW YORK, Jan. 11, 2025 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Dentsply Sirona Inc. XRAY between May 6, 2021 and November 6, 2024, both dates inclusive ( the "Class Period" ) , of the important January 27, 2025 lead ...

https://www.benzinga.com/pressreleases/25/01/g42933528/rosen-highly-recognized-investor-counsel-encourages-dentsply-sirona-inc-investors-to-secure-counse

Lowey Dannenberg Notifies Dentsply Sirona Inc. ( "Dentsply Sirona," "Dentsply," or the "Company" ) ( NASDAQ: XRAY ) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $100,000 in Losses to Contact the Firm - Dentsply Sirona ( NASDAQ:XRAY )

NEW YORK, Jan. 10, 2025 ( GLOBE NEWSWIRE ) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Dentsply Sirona Inc. ( "Dentsply Sirona," "Dentsply," or the "Company" ) XRAY for violations of the ...

https://www.benzinga.com/pressreleases/25/01/g42928152/lowey-dannenberg-notifies-dentsply-sirona-inc-dentsply-sirona-dentsply-or-the-company-nasdaq-xray-

Trending Today

XRP ($XRP) Crypto Forecast: Up 5.1% Today

dogwifhat ($WIF) Crypto Forecast: Up 5.3% Today

Bonk ($BONK) Crypto Forecast: Up 5.3% Today

Dogecoin ($DOGE) Crypto Forecast: Up 6.9% Today

Peanut Squirrel ($PNUT) Crypto Forecast: Up 14.5% Today

Penn National Gaming Inc. ($PENN) Stock Forecast: Up 5.6% Today

SushiSwap ($SUSHI) Crypto Forecast: Up 7.8% Today

Aave ($AAVE) Crypto Forecast: Up 5.7% Today

Hedera Hashgraph ($HBAR) Crypto Forecast: Up 7.1% Today

Ethereum ($ETH) Crypto Forecast: Up 6.5% Today

DENTSPLY SIRONA Inc. Price History

20.07.2024 - XRAY Stock was down 5.1%

• The bearish movement in XRAY stock today could be attributed to the unexpected departure of CFO Glenn Coleman, leading to uncertainty among investors.
• Investors may be concerned about the implications of a key executive leaving the company, potentially signaling internal issues or strategic changes.
• The departure of a CFO can sometimes indicate financial challenges or mismanagement, causing investors to react negatively and sell off shares of the company.

29.01.2024 - XRAY Stock was down 5.4%

• Despite higher sales reported for Q4 2023, the market may have reacted bearishly due to a net loss for FY23.
• The departure of a board member might have added to the negative sentiment surrounding the stock, signaling potential internal challenges.
• The mixed FY24 guidance offered by Dentsply Sirona could have contributed to investor uncertainty, leading to the bearish market movement.
• Overall, the combination of a net loss, board member departure, and uncertain future guidance likely influenced the bearish trend in XRAY stock today.

01.02.2024 - XRAY Stock was down 5.4%

• Despite higher sales for Q4 2023, Dentsply Sirona Inc. (XRAY) witnessed a strong bearish movement in the stock market today.
• The market reaction to the company's net loss for FY23, despite modest revenue growth, was negative.
• The upcoming departure of a board member might have also contributed to the bearish sentiment surrounding XRAY.
• Mention of challenging macro headwinds in the earnings report could have further reduced investor confidence, influencing the bearish market movement.

29.01.2024 - XRAY Stock was down 1.5%

• The bearish movement in XRAY stock could be attributed to the mixed FY24 guidance provided by Dentsply Sirona, despite posting a Q4 earnings beat.
• The net loss reported for FY23 amidst modest revenue growth might have also contributed to the negative sentiment surrounding the stock.
• The upcoming departure of a board member, Eric K. Brandt, could have added uncertainty and potential instability to the company's leadership, impacting investor confidence.
• Despite reporting higher sales for Q4 2023, the overall market reaction to the earnings summary may have been overshadowed by concerns over the company's financial performance and future outlook.

02.09.2024 - XRAY Stock was down 5.5%

• The decline in XRAY's stock price could be linked to various macroeconomic challenges, including weakened global demand, increased costs, and currency fluctuations.
• Despite its diverse product portfolio, these external factors appear to have impacted investor sentiment, leading to the stock's downturn.
• Investors may remain wary about the company's future performance until there is more clarity on DENTSPLY SIRONA's strategy to address the current economic challenges.

25.09.2024 - XRAY Stock was down 5.3%

• Dentsply Sirona's decision to voluntarily suspend sales and marketing of Byte Aligners and Impression Kits could have raised concerns among investors about the company's revenue stream and future growth prospects.
• The upcoming conference call to discuss updates on Byte Aligner products might have failed to reassure investors, leading to a lack of confidence in the company's ability to address the issues effectively.
• The select preliminary third-quarter results provided by Dentsply Sirona could have indicated weaker performance than expected, contributing to the negative sentiment surrounding the stock.

13.08.2024 - XRAY Stock was up 5.2%

• The launch of Primescan 2, the new-generation intraoral scanner, is anticipated to fuel growth and market sentiment for XRAY.
• The innovative technology is expected to draw in more customers and bolster the company's competitiveness in the dental equipment sector.
• Investors are positive about the potential rise in revenue and enhanced customer satisfaction resulting from Primescan 2, contributing to today's bullish market movement.

11.11.2024 - XRAY Stock was up 5.2%

• The bullish movement in XRAY stock could be attributed to investors finding reasons to retain Dentsply Sirona stock in their portfolios despite the ongoing challenges.
• The pending securities fraud class action lawsuit may have initially caused some uncertainty and volatility in the stock price, but investors seem to have gained confidence in the company's product portfolio.
• Despite the deadline alerts reminding investors of potential losses, the stock managed to have a strong bullish movement, indicating that some positive news or developments might have overshadowed these concerns.
• Overall, the market movement suggests that investors are focusing more on the company's product traction and potential growth rather than the pending legal issues and macroeconomic challenges.

07.10.2024 - XRAY Stock was down 25.2%

• Despite exceeding earnings and revenue expectations in the third quarter, Dentsply Sirona's stock faced downward pressure following a revised guidance for fiscal 2024.
• The revised forecast for 2024, attributed to macroeconomic factors, competition, and lower demand, elicited concerns among investors and led to a decline in the stock price.
• The market response may reflect apprehension surrounding future growth despite positive performance in specific segments during the quarter.
• Investors appear to be adopting a wary stance towards Dentsply Sirona until there is more clarity on the company's strategies to tackle the challenges affecting its future financial outlook.

07.10.2024 - XRAY Stock was down 19.9%

• The bearish movement in XRAY could be due to investors anticipating weaker-than-expected third-quarter earnings.
• Despite growth in specific segments like Wellspect Healthcare and Orthodontics, foreign exchange headwinds may have impacted overall performance.
• Investors might be taking a cautious approach, leading to a sell-off of XRAY shares before the earnings report.
• The uncertainty surrounding the company's financial performance in the face of external challenges could be driving the bearish sentiment in the market.

14.00.2025 - XRAY Stock was down 0.9%

• The decline in XRAY's stock price is potentially linked to ongoing securities class action lawsuits against the company.
• Investor sentiment appears to be negative due to concerns over legal uncertainties, prompting a sell-off of XRAY shares.
• There is a looming deadline for investors to secure counsel by January 27, 2025, which may be further impacting the stock price.
• Overall, market sentiment towards XRAY is bearish as investors assess the potential implications of the legal proceedings on the company's financial performance and reputation.

02.07.2024 - XRAY Stock was down 5.0%

• Second-quarter earnings of Dentsply Sirona (XRAY) were below analysts' expectations, with adjusted earnings per share and sales failing to meet estimates.
• Investor concerns about weak demand prompted the company to launch a restructuring plan, potentially impacting the stock's performance.
• Comparing the current figures to the previous year, the company experienced a decrease in both earnings and sales, influencing the negative market sentiment towards XRAY.
• Despite intentions to boost performance and shareholder value through restructuring and leadership adjustments, the initial reaction from investors may have triggered the downward movement in the stock price.